The Stem Cell Network is pleased to launch a new national research funding competition comprised of four translational research programs in stem cell and regenerative medicine. The first funding competition is for projects and clinical trials up to 25 months in length (January 1, 2020 – January 31, 2022). SCN anticipates that a second competition will be launched in early 2020. Together, $11 million will be made available through these peer-reviewed funding competitions to support Canadian stem cell research. Note: Funding is dependent on the completion of SCN’s 2019-22 contribution agreement with the Government of Canada.
Call for Proposals, applications welcome – June 13, 2019
Call for Proposals closes, application deadline – August 8, 2019 (11:59 PM Pacific Time)
Award notifications – December 2019
All applications must be emailed on or before the deadline to: Rebecca Cadwalader at firstname.lastname@example.org. A confirmation email will be sent within 48 hours of SCN receiving the submitted application package. If a confirmation email is NOT received from SCN within 48 hours of submission it is the responsibility of the lead applicant to contact SCN and ensure that the application package has been received.
Research Funding Programs
Accelerating Clinical Translation Program
The Accelerating Clinical Translation program supports multi-disciplinary research projects that are moving toward the clinic. This program will also support translational research activities (including ELSI questions) associated with an upcoming or ongoing clinical trial.
Fueling Biotechnology Partnerships Program
The Fueling Biotechnology Partnerships program supports academic partnerships with emerging Canadian regenerative medicine biotech companies who are working to drive an innovative stem cell-based technology or therapy into the clinic or market.
Advancing Clinical Trials Program
The Advancing Clinical Trials program supports early stage clinical trial projects with high translational potential. This program focuses on novel cellular or stem cell-related therapeutic approaches to tissue repair and regeneration for specific diseases. The clinical trials within this program will be led by academics working in leading Canadian research institutions and will bring forward innovative therapies or technologies of potential value to the Canadian health care system.
Translation and Society Program
The Translation & Society program supports ethical, legal and social implications (ELSI) projects that that focus on impediments to progress in the translation of innovative stem cell research.